Position in CBLL
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$472,284
-$202,663 QoQ
Shares Held
24,282
-34.1% QoQ
Ownership
0.063%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#65
of 123 holders
Holding Since
Dec 2024
7 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in CBLL Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Jun 30, 2026UBS Group AG holds $4,667,439,641 across 136 Medical Devices names. CBLL ranks #77 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | BSX |
Boston Scientific Corp
|
16,352,420 | $697,921,281 | |
| 2 | ABT |
Abbott Laboratories
|
7,356,093 | $667,491,874 | |
| 3 | SYK |
Stryker Corp
|
1,909,680 | $601,243,647 | |
| 4 | MDT |
Medtronic plc
|
5,551,443 | $434,289,383 | |
| 5 | DXCM |
Dexcom Inc
|
6,065,779 | $408,530,211 | |
| 6 | ZBH |
Zimmer Biomet Holdings, Inc.
|
2,758,615 | $237,489,163 | |
| 7 | PEN |
Penumbra Inc
|
703,822 | $222,231,795 | |
| 8 | EW |
Edwards Lifesciences Corp
|
2,350,656 | $212,640,338 |
All Filings in CBLL
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $472,284 | 24,282 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $674,947 | 36,822 | Shares | Defined | 2026-05-05 | |
| 2025-12-31 | $1,873,084 | 85,412 | Shares | Defined | 2026-01-29 | |
| 2025-09-30 | $2,951,999 | 256,919 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $2,798,955 | 149,437 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $383,258 | 19,951 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $923,553 | 35,686 | Shares | Sole | 2025-02-14 | |
| No filing history on record for this holder in this stock. | ||||||